Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG8V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,698
Award facts
- Contract value 100% obligated
- $24,697.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,698 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with an ultimate completion date of January 30, 2026. The contract, which carries no set-aside designation, reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operational entity for this award, with Cencora, Inc. (doing business as AmerisourceBergen) serving as the parent organization. The place of performance is listed at the company's Conshohocken facility.
Tezspire is a specialty biologic medication used in the treatment of severe asthma, and this delivery order represents one of numerous pharmaceutical procurement actions executed through the DLA's comprehensive medical supply chain network. The award demonstrates AmerisourceBergen's established capability as a critical federal pharmaceutical vendor supplying specialty medications, brand-name drugs, and medical devices to military healthcare programs and other federal medical institutions. The firm fixed-price structure and rapid completion timeline reflect typical operational patterns for urgent pharmaceutical procurement supporting Defense Health Agency and military treatment facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FJG8V?
SPE2DR26FJG8V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FJG8V worth?
The government has obligated $24,698 on SPE2DR26FJG8V.
Is contract SPE2DR26FJG8V an order under another contract?
Yes. SPE2DR26FJG8V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG8V competed?
The extent of competition for SPE2DR26FJG8V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award